NASDAQ:BIMI

BOQI International Medical Competitors

$1.38

+0.03 (+2.22 %)

(As of 05/7/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.34

▼

$1.43

50-Day Range

$1.35

▼

$1.87

52-Week Range

$1.32

▼

$4.09

Volume331,406 shs

Average Volume1.12 million shs

Market Capitalization$27.78 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.07

BOQI International Medical (NASDAQ:BIMI) Vs. PH, CR, WTS, B, HLIO, and MWA

Should you be buying BIMI stock or one of its competitors? Companies in the industry of "miscellaneous fabricated metal products" are considered alternatives and competitors to BOQI International Medical, including Parker-Hannifin (PH), Crane (CR), Watts Water Technologies (WTS), Barnes Group (B), Helios Technologies (HLIO), and Mueller Water Products (MWA).

BOQI International Medical vs. Parker-Hannifin Stock

Parker-Hannifin (NYSE:PH) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares Parker-Hannifin and BOQI International Medical's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Parker-Hannifin	$13.70 billion	3.01	$1.21 billion	$10.79	29.59
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Parker-Hannifin has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Parker-Hannifin and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Parker-Hannifin	8.75%	22.77%	7.13%
BOQI International Medical	N/A	1.73%	0.54%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Parker-Hannifin and BOQI International Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Parker-Hannifin	0	1	12	0	2.92
BOQI International Medical	0	0	0	0	N/A

Parker-Hannifin currently has a consensus price target of $323.6154, suggesting a potential upside of 1.36%. Given Parker-Hannifin's higher probable upside, equities analysts clearly believe Parker-Hannifin is more favorable than BOQI International Medical.

Institutional & Insider Ownership

77.4% of Parker-Hannifin shares are held by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are held by institutional investors. 1.5% of Parker-Hannifin shares are held by insiders. Comparatively, 29.6% of BOQI International Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Parker-Hannifin has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Summary

Parker-Hannifin beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

BOQI International Medical vs. Crane Stock

Crane (NYSE:CR) and BOQI International Medical (NASDAQ:BIMI) are both multi-sector conglomerates companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares Crane and BOQI International Medical's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crane	$3.28 billion	1.76	$133.30 million	$6.02	16.48
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Crane has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Crane and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Crane	0.71%	18.09%	5.80%
BOQI International Medical	N/A	1.73%	0.54%

Volatility and Risk

Crane has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Crane and BOQI International Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crane	0	1	3	0	2.75
BOQI International Medical	0	0	0	0	N/A

Crane currently has a consensus price target of $92.6667, suggesting a potential downside of 6.59%. Given Crane's higher probable upside, equities analysts clearly believe Crane is more favorable than BOQI International Medical.

Institutional & Insider Ownership

65.9% of Crane shares are held by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are held by institutional investors. 3.6% of Crane shares are held by insiders. Comparatively, 29.6% of BOQI International Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Crane beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

BOQI International Medical vs. Watts Water Technologies Stock

Watts Water Technologies (NYSE:WTS) and BOQI International Medical (NASDAQ:BIMI) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Watts Water Technologies and BOQI International Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Watts Water Technologies	$1.60 billion	2.86	$131.50 million	$4.07	33.50
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Watts Water Technologies has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Watts Water Technologies and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Watts Water Technologies	7.67%	13.15%	7.45%
BOQI International Medical	N/A	1.73%	0.54%

Risk & Volatility

Watts Water Technologies has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Watts Water Technologies and BOQI International Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Watts Water Technologies	0	3	0	0	2.00
BOQI International Medical	0	0	0	0	N/A

Watts Water Technologies currently has a consensus price target of $124.00, suggesting a potential downside of 9.05%. Given Watts Water Technologies' higher probable upside, equities research analysts plainly believe Watts Water Technologies is more favorable than BOQI International Medical.

Institutional and Insider Ownership

75.0% of Watts Water Technologies shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 1.1% of Watts Water Technologies shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Watts Water Technologies beats BOQI International Medical on 8 of the 10 factors compared between the two stocks.

BOQI International Medical vs. Barnes Group Stock

Barnes Group (NYSE:B) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Barnes Group and BOQI International Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Barnes Group	$1.49 billion	1.82	$158.35 million	$3.21	16.72
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Barnes Group has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Barnes Group and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Barnes Group	7.19%	8.63%	4.14%
BOQI International Medical	N/A	1.73%	0.54%

Risk & Volatility

Barnes Group has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Barnes Group and BOQI International Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Barnes Group	3	5	2	0	1.90
BOQI International Medical	0	0	0	0	N/A

Barnes Group currently has a consensus price target of $42.20, suggesting a potential downside of 21.39%. Given Barnes Group's higher probable upside, equities research analysts plainly believe Barnes Group is more favorable than BOQI International Medical.

Institutional and Insider Ownership

86.0% of Barnes Group shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 8.4% of Barnes Group shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Barnes Group beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

BOQI International Medical vs. Helios Technologies Stock

Helios Technologies (NASDAQ:HLIO) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Helios Technologies and BOQI International Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helios Technologies	$554.66 million	4.41	$60.27 million	$2.43	31.26
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Helios Technologies has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Helios Technologies and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Helios Technologies	4.52%	12.24%	6.96%
BOQI International Medical	N/A	1.73%	0.54%

Risk & Volatility

Helios Technologies has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Helios Technologies and BOQI International Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helios Technologies	0	1	1	0	2.50
BOQI International Medical	0	0	0	0	N/A

Helios Technologies currently has a consensus price target of $79.00, suggesting a potential upside of 4.02%. Given Helios Technologies' higher probable upside, equities research analysts plainly believe Helios Technologies is more favorable than BOQI International Medical.

Institutional and Insider Ownership

87.3% of Helios Technologies shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 4.1% of Helios Technologies shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Helios Technologies beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

BOQI International Medical vs. Mueller Water Products Stock

Mueller Water Products (NYSE:MWA) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Institutional and Insider Ownership

84.6% of Mueller Water Products shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 1.5% of Mueller Water Products shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Mueller Water Products and BOQI International Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mueller Water Products	$964.10 million	2.45	$72 million	$0.52	28.62
BOQI International Medical	$160,000.00	173.63	$-4,440,000.00	N/A	N/A

Mueller Water Products has higher revenue and earnings than BOQI International Medical.

Risk & Volatility

Mueller Water Products has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Profitability

This table compares Mueller Water Products and BOQI International Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mueller Water Products	7.47%	13.39%	6.11%
BOQI International Medical	N/A	1.73%	0.54%

Analyst Ratings

This is a summary of current ratings and recommmendations for Mueller Water Products and BOQI International Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mueller Water Products	0	1	3	0	2.75
BOQI International Medical	0	0	0	0	N/A

Mueller Water Products currently has a consensus price target of $13.00, suggesting a potential downside of 12.63%. Given Mueller Water Products' higher probable upside, equities research analysts plainly believe Mueller Water Products is more favorable than BOQI International Medical.

Summary

Mueller Water Products beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.